RSM logo
JRSM

Home Current issue Browse archive Alerts About the journal Feedback
 
J R Soc Med 2000;93:72-74
© 2000 Royal Society of Medicine

This Article
Right arrow Full Text (PDF)
Right arrow Send a Quick Comment
Right arrow Alert me when this article is cited
Right arrow Alert me when Quick Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Courtenay, M.
Right arrow Articles by Ryan, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of the Royal Society of Medicine, Vol 93, Issue 2 72-74, Copyright © 2000 by Royal Society of Medicine

ORIGINAL ARTICLES

Larva therapy in wound management

M Courtenay, JC Church and TJ Ryan
Churchill Hospital, Department of Dermatology, Headington, Oxford, UK.

The use of maggots for wound debridement has a long history and has lately gained ground in several countries. We collected prospective data to examine the current use of larva therapy (LT) in the UK. Quantitative information was collected on 70 patients treated in nine hospitals. LT is used primarily to treat leg ulcers and generally involves three applications of larvae at two to three day intervals. This method is judged effective in wound debridement and promotes the growth of granulation tissue. Wound exudate, odour, infection and pain are all reduced by the treatment. Adverse reactions are infrequent but include pain, bleeding, pyrexia and influenza-like symptoms. Prevention of hospital admission and surgery, reduced need for antibiotics and reduced hospital stay are all identified as outcomes of LT. The nurse practitioners who used LT believed it to have an important role in wound management. A randomized clinical trial, comparing LT with other debriding agents, is required for evaluation of cost effectiveness.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 AM J HOSP PALLIAT CAREHome page
P. Steenvoorde, L. P. van Doorn, C. E. Jacobi, and J. Oskam
Maggot Debridement Therapy in the Palliative Setting
American Journal of Hospice and Palliative Medicine, September 1, 2007; 24(4): 308 - 310.
[Abstract] [PDF]

Home page
 Postgrad. Med. J.Home page
I. S Whitaker, C. Twine, M. J Whitaker, M. Welck, C. S Brown, and A. Shandall
Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential
Postgrad. Med. J., June 1, 2007; 83(980): 409 - 413.
[Abstract] [Full Text] [PDF]

Home page
 INT J LOW EXTREM WOUNDSHome page
P. Steenvoorde and J. Oskam
Letter to the Editor
International Journal of Lower Extremity Wounds, March 1, 2005; 4(1): 57 - 58.
[PDF]

Home page
 INT J LOW EXTREM WOUNDSHome page
J. C. T. Church and M. Courtenay
Maggot Debridement Therapy for Chronic Wounds
International Journal of Lower Extremity Wounds, June 1, 2002; 1(2): 129 - 134.
[Abstract] [PDF]



 BMJ Journal of Medical Ethics RSM Press eJournals Collection 2010